State to compensate "Biosintez" part of costs for clinical trial of drugs
Penza, 25 January 2017. PenzaNews. The Ministry of Industry and Trade of the Russian Federation and the Penza company "Biosintez" concluded the contract for the provision of subsidies for compensation of a part of expenses on organization and conducting clinical trials of the medicinal product "Mialays gel for external use 1%" for patients with osteoarthritis of a knee. This was reported by the press service of the regional Ministry of Industry.
© PenzaNewsBuy the photo
"In accordance with the objectives of the state programme 'Pharma-2020' on the provision of the health system with safe domestic medicine of high quality, the LLC 'Biosintez' is constantly involved in the development and exploration of high-quality affordable import-substituting medicine," the department noted.
The press service specified that over the last 5 years, the variety of "Biosintez" import-substituting products increased by 22 types of medicine.
"The state support that the company will receive will speed up the entrance of LLC ‘Biosintez’ import-substituting products to the Russian market," the Ministry of Industry of the Penza region emphasized.